Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 8201 | 1209 | 28.0 | 44% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 545 | 13948 | REBAMIPIDE//GASTRIC MUCOSAL BLOOD FLOW//GASTRIC MUCOSA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ENPROSTIL | Author keyword | 8 | 50% | 1% | 12 |
| 2 | E2 PROSTAGLANDINS | Author keyword | 6 | 80% | 0% | 4 |
| 3 | NOCLOPROST | Author keyword | 2 | 44% | 0% | 4 |
| 4 | FHS 74 CELLS | Author keyword | 2 | 67% | 0% | 2 |
| 5 | E 2 PROSTAGLANDINS | Author keyword | 1 | 100% | 0% | 2 |
| 6 | IEC CELLS | Author keyword | 1 | 100% | 0% | 2 |
| 7 | MED PHASE 1 | Address | 1 | 100% | 0% | 2 |
| 8 | ANTISECRETORY POTENCY | Author keyword | 1 | 50% | 0% | 1 |
| 9 | ARBAPROSTIL | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ASPIRINR | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ENPROSTIL | 8 | 50% | 1% | 12 | Search ENPROSTIL | Search ENPROSTIL |
| 2 | E2 PROSTAGLANDINS | 6 | 80% | 0% | 4 | Search E2+PROSTAGLANDINS | Search E2+PROSTAGLANDINS |
| 3 | NOCLOPROST | 2 | 44% | 0% | 4 | Search NOCLOPROST | Search NOCLOPROST |
| 4 | FHS 74 CELLS | 2 | 67% | 0% | 2 | Search FHS+74+CELLS | Search FHS+74+CELLS |
| 5 | E 2 PROSTAGLANDINS | 1 | 100% | 0% | 2 | Search E+2+PROSTAGLANDINS | Search E+2+PROSTAGLANDINS |
| 6 | IEC CELLS | 1 | 100% | 0% | 2 | Search IEC+CELLS | Search IEC+CELLS |
| 7 | ANTISECRETORY POTENCY | 1 | 50% | 0% | 1 | Search ANTISECRETORY+POTENCY | Search ANTISECRETORY+POTENCY |
| 8 | ARBAPROSTIL | 1 | 50% | 0% | 1 | Search ARBAPROSTIL | Search ARBAPROSTIL |
| 9 | ASPIRINR | 1 | 50% | 0% | 1 | Search ASPIRINR | Search ASPIRINR |
| 10 | C 14 ARACHIDONIC ACID | 1 | 50% | 0% | 1 | Search C+14+ARACHIDONIC+ACID | Search C+14+ARACHIDONIC+ACID |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | E2 PROSTAGLANDINS | 9 | 59% | 1% | 10 |
| 2 | PROSTAGLANDIN E2 INDUCED HYPERPLASIA | 6 | 100% | 0% | 4 |
| 3 | ENPROSTIL | 5 | 44% | 1% | 8 |
| 4 | 15R 15 METHYL PROSTAGLANDIN E2 ARBAPROSTIL | 3 | 100% | 0% | 3 |
| 5 | ARBAPROSTIL | 3 | 100% | 0% | 3 |
| 6 | LUMINAL PROSTAGLANDIN E2 | 3 | 100% | 0% | 3 |
| 7 | LIEBERKUHN | 2 | 67% | 0% | 2 |
| 8 | SC 29333 | 2 | 67% | 0% | 2 |
| 9 | SYNTHETIC PROSTAGLANDIN E2 ANALOG | 2 | 67% | 0% | 2 |
| 10 | RABBIT PARIETAL CELLS | 2 | 19% | 1% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| MISOPROSTOL - DISCOVERY, DEVELOPMENT, AND CLINICAL-APPLICATIONS | 1990 | 69 | 57 | 67% |
| PROTECTIVE EFFECTS OF PROSTAGLANDINS AGAINST GASTRIC-MUCOSAL DAMAGE - CURRENT KNOWLEDGE AND PROPOSED MECHANISMS | 1983 | 507 | 78 | 44% |
| PROSTAGLANDINS AND THE GASTROINTESTINAL MUCOSA - ARE THEY IMPORTANT IN ITS FUNCTION, DISEASE, OR TREATMENT | 1985 | 337 | 140 | 34% |
| ENPROSTIL - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE TREATMENT OF PEPTIC-ULCER DISEASE | 1987 | 31 | 32 | 84% |
| MISOPROSTOL - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE TREATMENT OF PEPTIC-ULCER DISEASE | 1987 | 43 | 67 | 63% |
| CLASSICAL ABSORPTION THEORY AND THE DEVELOPMENT OF GASTRIC-MUCOSAL DAMAGE ASSOCIATED WITH THE NONSTEROIDAL ANTIINFLAMMATORY DRUGS | 1987 | 47 | 22 | 45% |
| PARIETAL-CELL PREPARATION AND ARACHIDONATE METABOLISM | 1990 | 5 | 7 | 86% |
| PROSTAGLANDINS IN PEPTIC-ULCER DISEASE - AN OVERVIEW OF CURRENT STATUS AND FUTURE-DIRECTIONS | 1986 | 44 | 27 | 56% |
| SOUTHWESTERN INTERNAL-MEDICINE CONFERENCE - PROSTAGLANDINS AND GASTRIC-ULCERS - FROM SEMINAL-VESICLE TO MISOPROSTOL (CYTOTEC) | 1990 | 8 | 104 | 56% |
| A SYNTHETIC ANALOG OF PROSTAGLANDIN-E2 (ENPROSTIL) IN ESSENTIAL-HYPERTENSION TREATMENT | 1991 | 1 | 28 | 93% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED PHASE 1 | 1 | 100% | 0.2% | 2 |
| 2 | GLOSTRUP HOSP MED ENGN | 1 | 50% | 0.1% | 1 |
| 3 | GLOSTRUP HOSP SURG GASTROENTEROL D | 1 | 50% | 0.1% | 1 |
| 4 | IMMUNOINFLAMMATORY DIS | 1 | 50% | 0.1% | 1 |
| 5 | SECT ENDOCRINOL PHARMACOL | 1 | 50% | 0.1% | 1 |
| 6 | PHARMACOL BOX 60400 | 0 | 33% | 0.1% | 1 |
| 7 | VDPAM | 0 | 33% | 0.1% | 1 |
| 8 | SERV ENDOCRINOL EXPT | 0 | 25% | 0.1% | 1 |
| 9 | MED HISTOL CELL BIOL | 0 | 20% | 0.1% | 1 |
| 10 | PHASE SERV 1 | 0 | 20% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000231853 | SURGICAL VAGOTOMY//ACUTE SURGICAL VAGOTOMY//GASTRIC MUCOSAL BIOCHEMISTRY |
| 2 | 0.0000217422 | DUODENAL HCO3 SECRETION//DUODENAL MUCOSAL PROTECTION//BICARBONATE SECRETION |
| 3 | 0.0000202332 | GASTROPROTECTION//GASTRIC ULCER//GASTROPROTECTIVE |
| 4 | 0.0000161894 | SUCRALFATE//PEPTIC ULCER THERAPY//DE NOL |
| 5 | 0.0000146556 | SPATHOLOBI CAULIS//EHU MED FISIOL POB 699//RABBIT PARIETAL CELLS |
| 6 | 0.0000086427 | EBROTIDINE//SOFALCONE//SULGLYCOTIDE |
| 7 | 0.0000084516 | PEPSINOGEN SECRETION//GASTRIC MUCIN SECRETION//NAKAHARI PROJECT |
| 8 | 0.0000083111 | NSAIDS//COXIBS//ROFECOXIB |
| 9 | 0.0000080846 | GASTRIC SURFACTANT//PHOSPHOLIPID COMPLEX//PHARMACOSOMES |
| 10 | 0.0000069382 | LAFUTIDINE//CAPSAICIN SENSITIVE SENSORY NEURON//GASTRIC MUCIN BIOSYNTHESIS |